Jeff Cohen was 17 years old and lived in Baltimore when mononucleosis dropped her with his feet. He thinks he obtained him from his girlfriend from the school – now his wife – who, once sick, would sound the door, would place his duties and face it before he could go to the door. “She was afraid to give him something,” said Cohen, who was deposited for a week with fever, sore throat and swollen glands. “I’m sure it comes from her.”
This adolescent case of Mono, also known as the glandular fever, would make a lasting impression. Five decades later, Cohen is now head of the infectious disease laboratory within the National Institutes of Health, where he has efforts to create a vaccine for the Epstein-Barr, or EBV virus, which causes a mono.
